BHI Therapeutic Sciences supports scientific research and education in stem cell and regenerative medicine, in collaboration with leading institutions, scientists, and physicians across the globe.

We only utilize stem cells from either your own body (autologous) or from umbilical cord donors who have proceeded through a multiple step testing process that ensures stem cell patient safety. We do not use embryonic stem cells, nor will we ever.

BHI Therapeutic Sciences has US board-certified physicians on staff. Our Scientific Advisory Board and Ethics Committee oversee research protocols to support high standards of research conduct and participant safety.

BHI Therapeutic Sciences was formed with the mission to advance stem cell and regenerative-medicine research in full regulatory conformance and in conjunction with the scientific community. The team includes US board-certified physicians and an experienced Scientific Advisory Board that oversees research protocols to support high standards of research conduct and participant safety.

BHI Therapeutic Sciences supports research and innovation in regenerative medicine. By supporting research that addresses unmet medical needs, we aim to contribute to the responsible advancement of regenerative medicine.

Excellence: BHITS aims for excellence in all areas of our work, including patient care and scientific research and development. We support research that adheres to high standards of quality and scientific rigor.

Teamwork: We aggressively seek partnerships with top organizations, researchers, and medical professionals because we believe in the power of teamwork. Together, we can advance regenerative medicine more quickly by utilizing our pooled knowledge.

Patient-Centricity: Our approach places the needs of our patients first. Their safety, wellbeing, and accessibility to efficient therapies are our top priorities. Our primary goals are to raise the quality of life and improve the results for patients.

Innovation: BHITS welcomes innovation as a factor behind advancements in regenerative medicine. To develop the field and provide patients with novel therapies, we continuously investigate new theories, technologies, and strategies.

Ethics and Integrity: In all aspects of our business, including research and development, we uphold the highest ethical standards. In all our interactions, we uphold openness, honesty, and responsible decision-making, and we are committed to the ethical use of stem cells in our research.

Global Impact: By increasing access to our therapies and working with healthcare specialists around the world, we are dedicated to having a positive global impact. Our goal is to help progress healthcare internationally and enhance patient outcomes.

BHI Therapeutic Sciences’ quest of excellence, innovation, and patient-centered care is guided by their mission, vision, and values. They demonstrate our dedication to changing the course of healthcare and altering lives through regenerative medicine.

Company Background

BHITS possesses a rich research background, with numerous publications in peer reviewed USA and international journals. We are a dedicated research institute that has been actively working for over a decade to perfect stem cell and other regenerative medicine therapies. This is reflected in a substantial body of peer-reviewed publications in U.S. and international journals across more than a decade of research in stem cell and regenerative medicine.

Stem cells and related regenerative-medicine approaches are an active area of scientific investigation. Our work focuses on studying these approaches in research settings under ethical and institutional oversight. These investigational approaches have not been shown to be safe or effective for any disease or condition and are not intended to diagnose, treat, cure, or prevent any disease. Any cosmetic products we develop are intended only to improve the appearance of skin and make no therapeutic claims.

BHI Therapeutic Sciences at a glance:

• 10 years of published articles in top journals in the field of stem cell research

• Research protocols developed over more than a decade of stem cell research

• 9 Grant and clinical applications submitted to the USA National Institutes for Health and the Department of Defense

• Established research institute with training modules designed to educate our local team members in the highest quality cell culture techniques and research study compliance.

Our research has been published in “Experimental and Therapeutic Medicine” cited at PubMed Central, US National Library of Medicine, National Institutes of Health; and “CellR4”, the official journal of The Cure Alliance, among others.

BHI Therapeutic Sciences stem cell products are evaluated in clinical studies and are collected in accordance with Good Tissue Practice to ensure safety.

Our cellular and exosome products are investigational. They have not been shown to be safe or effective for any disease or condition, and no safety or efficacy conclusions should be drawn from our research activities.